Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

…, J Mares, R Kozel, D Kopecka, V Zindr… - The lancet respiratory …, 2019 - thelancet.com
Background Benralizumab is an interleukin-5 receptor α-directed cytolytic monoclonal
antibody that has been shown to safely reduce exacerbations and improve lung function for …

[PDF][PDF] Chronic Obstructive Pulmonary Disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel …

V Koblizek, J Chlumsky, V Zindr… - … Papers of the …, 2013 - biomed.papers.upol.cz
Background. COPD is a global concern. Currently, several sets of guidelines, statements and
strategies to managing COPD exist around the world. Methods. The Czech Pneumological …

[PDF][PDF] Doporučený postup diagnostiky a léčby bronchiálního astmatu

…, B Novotná, P Panzner, E Seberová, V Sedlák, V Zindr… - Semily: Geum, 2015 - csaki.cz
Doporučený postup diagnostiky a léčby bronchiálního astmatu je společným dokumentem
České společnosti alergologie a klinické imunologie (ČSAKI) a České pneumologické a …

RETRO-POPE: A Retrospective, Multicenter, Real-World Study of All-Cause Mortality in COPD

…, J Kocianova, S Holub, V Zindr… - … Journal of Chronic …, 2023 - Taylor & Francis
Purpose The Phenotypes of COPD in Central and Eastern Europe (POPE) study assessed
the prevalence and clinical characteristics of four clinical COPD phenotypes, but not mortality. …

GOLD and phenotypes: The new Czech COPD guidelines

V Koblizek, J Chlumsky, V Zindr, J Kocianova… - 2015 - Eur Respiratory Soc
Background: The Czech Pneumological and Phthisiological Society (CPPS) has prepared
new national guidelines. Diagnosis: The essential requirement for the diagnosis of COPD is …

Chronic Obstructive Pulmonary Disease: Diagnosis and Treatment Guidelines of the Czech Pneumological and Phthisiological Society (CPPS)

V Koblizek, J Chlumsky, V Zindr, V Sedlak, J Satinska… - Chest, 2013 - journal.chestnet.org
PURPOSE: COPD is a global phenomenon. Currently in the world there are several parallel,
not entirely compatible, medical statements and strategies. The authors aim to present new …

Discordance between a patient completed COPD Assessment test (CAT) and a CAT completed by patient with physician assistance

V Koblížek, V Zindr, J Kocianova, S Holub… - 2017 - Eur Respiratory Soc
Introduction: COPD Assessment Test (CAT) is a patient-completed questionnaire widely
used to quantify COPD impact.Unfortunately, completion of the questionnaire by the elderly …

Phenotypes and cluster analysis as predictors of survival in a real-life COPD cohort (RETRO-POPE Study)

…, M Svoboda, J Kocianova, S Holub, V Zindr… - 2023 - Eur Respiratory Soc
Background: COPD is a major cause of morbidity and mortality. Despite this, there are very
little data regarding COPD mortality in Central and Eastern Europe (CEE). The Phenotypes of …

Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic …

DT Cheng, DK Kim, DA Cockayne… - American journal of …, 2013 - atsjournals.org
Rationale: Emphysema in chronic obstructive pulmonary disease (COPD) can be characterized
by high-resolution chest computed tomography (HRCT); however, the repeated use of …

[HTML][HTML] Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive …

DP Tashkin, SI Rennard, P Martin, S Ramachandran… - Drugs, 2008 - Springer
Background: The combination of an inhaled corticosteroid (ICS) and a long-acting
bronchodilator is recommended in the treatment of patients with chronic obstructive pulmonary …